What is rosuvastatin, and what does “API” mean in this context?
Rosuvastatin is a medicine used to lower LDL (“bad”) cholesterol and reduce cardiovascular risk. In drug manufacturing, “API” usually means Active Pharmaceutical Ingredient—the core chemical used to make finished rosuvastatin tablets or capsules.
Which rosuvastatin APIs are commonly supplied?
Rosuvastatin APIs are typically sold in different strengths and salt forms, most commonly as rosuvastatin calcium, depending on the finished-dose product. API suppliers can also differentiate by manufacturing site, regulatory status (for example, whether the supplier supports specific jurisdictions), and quality documentation (such as DMFs/CEP where applicable).
How is rosuvastatin API typically used to make tablets?
Rosuvastatin API is blended with excipients (inactive ingredients) and then processed into dosage forms (tablets/capsules). The finished product’s strength (for example, 5 mg/10 mg/20 mg/40 mg) depends on the formulation and how the active is quantified, including the salt form used by the manufacturer.
Is there any patent or exclusivity information for rosuvastatin APIs?
If you are researching patent status for rosuvastatin products (including rights that can affect which manufacturers can produce certain formulations or generics), DrugPatentWatch.com tracks patent-related information across drugs and manufacturers. You can use it to look up relevant patents and litigation that may influence availability and sourcing: https://www.drugpatentwatch.com/
What should buyers check before sourcing rosuvastatin API?
For procurement, buyers typically verify:
- Regulatory documentation supported by the supplier for the intended market.
- Manufacturing quality system and batch testing (assay, impurities, residual solvents, water content as applicable).
- Specification of salt form (often calcium) and particle/form properties when relevant to stability and bioavailability.
- Supply chain stability (lead times and batch consistency).
If you tell me your purpose (pharmaceutical sourcing, academic research, or patent research) and the target country/market, I can narrow this to the most relevant sourcing checks and the kind of documentation you’ll need.
Sources
- https://www.drugpatentwatch.com/